Ruud C. Wortel

Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

Luca Incrocci, Ruud C. Wortel, Wendimagegn Alemayehu et al. · The Lancet Oncology · 2016 · 478 citations

Medicine, Radiation Oncology, Urology +14

Acute Toxicity After Image-Guided Intensity Modulated Radiation Therapy Compared to 3D Conformal Radiation Therapy in Prostate Cancer Patients

Ruud C. Wortel, Luca Incrocci, Floris J. Pos et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 122 citations

Medicine, Oncology, Radiation Oncology +16

Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts

Ruud C. Wortel, Luca Incrocci, Floris J. Pos et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 103 citations

Medicine, Oncology, Radiation Oncology +17

Dose–surface maps identifying local dose–effects for acute gastrointestinal toxicity after radiotherapy for prostate cancer

Ruud C. Wortel, Marnix G. Witte, Uulke A. van der Heide et al. · Radiotherapy and Oncology · 2015 · 60 citations

Medicine, Oncology, Radiation Oncology +17

Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial

Kim C. de Vries, Ruud C. Wortel, Esther Oomen‐de Hoop et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 58 citations

Medicine, Oncology, Radiation Oncology +17